Citation: Sj. Brister et al., THROMBIN GENERATION DURING CARDIAC-SURGERY - IS HEPARIN THE IDEAL ANTICOAGULANT, Thrombosis and haemostasis, 70(2), 1993, pp. 259-262
Authors:
FALANGA A
OFOSU FA
DEWAR L
DELAINI F
OLDANI E
BARBUI T
Citation: A. Falanga et al., EVIDENCE FOR PROTHROMBIN ACTIVATION AND IMPAIRED THROMBIN INHIBITION IN CANCER-PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 573-573
Citation: Sj. Brister et al., THROMBIN GENERATION DURING CARDIAC-SURGERY - IS HEPARIN THE IDEAL ANTICOAGULANT, Thrombosis and haemostasis, 69(6), 1993, pp. 654-654
Citation: Mr. Buchanan et al., SIMULTANEOUS INHIBITION OF THROMBIN BY ATIII AND HCII AND PREVENTION OF THROMBUS FORMATION AND GROWTH - RELATIVE EFFECTS OF HEPARIN AND SULODEXIDE, Thrombosis and haemostasis, 69(6), 1993, pp. 667-667
Authors:
BUCHANAN MR
BRISTER SJ
LIAO P
WARNKE C
OFOSU FA
Citation: Mr. Buchanan et al., EFFECTS OF HEPARIN AND DERMATAN SULFATE ON INJURED VESSEL WALL HYPERPLASIA AND VESSEL WALL OCCLUSION, Thrombosis and haemostasis, 69(6), 1993, pp. 807-807
Authors:
LIU LB
FREEDMAN J
HORNSTEIN A
DEWAR L
OFOSU FA
Citation: Lb. Liu et al., EFFECTS OF SELECTIVE THROMBIN OR FACTOR-XA INHIBITORS ON THE ASSEMBLYOF PLATELET-BOUND PROTHROMBINASE IN PLASMA, Thrombosis and haemostasis, 69(6), 1993, pp. 812-812
Authors:
BRISTER SJ
OFOSU FA
GIANESE F
HEIGENHAUSER GF
BUCHANAN MR
Citation: Sj. Brister et al., DERMATAN SULFATE PREVENTS PROTHROMBIN CONSUMPTION DURING CARDIOPULMONARY BYPASS MORE EFFECTIVELY THAN HEPARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 890-890
Authors:
LIU LB
BLAJCHMAN MA
ANDREW M
GINSBERG J
DEWAR L
DELORME M
OFOSU FA
Citation: Lb. Liu et al., EVIDENCE FOR HEPARIN COFACTOR-II (HCII) AS A PHYSIOLOGICAL INHIBITOR OF THROMBIN, Thrombosis and haemostasis, 69(6), 1993, pp. 899-899
Authors:
OKWUSIDI J
ANVARI N
BEVILACQUA C
OFOSU FA
Citation: J. Okwusidi et al., CONSEQUENCES OF THE INTERACTIONS OF FIBRINOGEN, FIBRIN-I AND GLYCOSAMINOGLYCANS ON PROTHROMBIN ACTIVATION IN HUMAN PLASMA, Thrombosis and haemostasis, 69(6), 1993, pp. 1260-1260
Citation: Q. Chen et al., FACTOR-VII HAMILTON - A NOVEL TYPE-2 MUTATION LOCATED AT RESIDUE-57 IN THE 1ST EGF DOMAIN OF HUMAN FACTOR-VII, Thrombosis and haemostasis, 69(6), 1993, pp. 1291-1291
Citation: Fa. Ofosu, PROPHYLACTIC DOSES OF ENOXAPARIN AND HEPARIN INHIBIT PROTHROMBIN ACTIVATION, Seminars in thrombosis and hemostasis, 19, 1993, pp. 29-30
Authors:
SRIDHARA S
CLARKE BJ
OFOSU FA
HIGH KA
BLAJCHMAN MA
Citation: S. Sridhara et al., THE DIRECT BINDING OF HUMAN FACTOR-VII IN PLASMA TO RECOMBINANT HUMANTISSUE FACTOR, Thrombosis research, 70(4), 1993, pp. 307-316
Citation: Mr. Buchanan et al., RELATIVE EFFECTS OF HEPARIN AND SULODEXIDE ON PREVENTION OF THROMBUS FORMATION AND GROWTH, Thrombosis research, 70, 1993, pp. 161-161
Authors:
FALANGA A
OFOSU FA
CORTELAZZO S
DELAINI F
CONSONNI R
CACCIA R
LONGATTI S
MARAN D
RODEGHIERO F
POGLIANI E
MARASSI A
DANGELO A
BARBUI T
Citation: A. Falanga et al., PRELIMINARY-STUDY TO IDENTIFY CANCER-PATIENTS AT HIGH-RISK OF VENOUS THROMBOSIS FOLLOWING MAJOR SURGERY, British Journal of Haematology, 85(4), 1993, pp. 745-750